News - Archive
BioMed Alliance Code of Conduct underlines ethical integrity for patient benefit.
- Details
H2020’s opportunities and challenges – BioMed Alliance event in the European Parliament, November 29th, 2016
- Details
Presentations
{gallery}h2020{/gallery}
The strategic meeting with the Presidents of the BioMed Alliance member societies, November, 29th, 2016
- Details
BioMed Alliance General Annual Meeting, November, 9th, 2016.
- Details
Presentations
The Scientific Panel for Health - Prof. Karin SIPIDO, Chair of the Scientific Panel for Health
Medical Education Activities - Marie-Claire PICKAERT, Deputy Director General, EFPIA
{gallery}annual-meeting-2016{/gallery}
Upcoming BioMed Alliance meetings
- Details
BioMed Alliance Policy Officer: 8th of November (9:00-12:30), at BioMed Alliance office
General Assembly 2016: 9th of November (9:00 – 16:00), at the Sofitel Le Louise Hotel, Brussels.
An official dinner will be organized on 8th of November (20:00 – 22:00) at the same hotel.
Strategic meeting with Presidents of BioMed Alliance member societies: 29th of November, at BioMed Alliance office.
BioMed Alliance Event in the European Parliament: 29th of November (12:00-14:00)
The Biomed Alliance’s leadership attended the Science and Europe event to honor the life and legacy of José Mariano Gago (1948-2015). On this occasion, Prof. Ulf Smith gave a laudation.
- Details
Members of the Alliance for Biomedical Research in Europe (BioMed Alliance) have approved the Code of Conduct of healthcare professionals and scientific organizations
- Details
The Alliance for Biomedical Research in Europe supports the More Trials campaign for more, better, randomized trials.
- Details
Save the date : BioMed Alliance meetings
- Details
- Spring meeting: 2016 April 15th
- General Assembly: 2016 November 9th
- Policy officers meeting 2016 June 16th
- Policy officers meeting 2016 November 8th
BioMed Alliance General Annual Meeting, November, 13th, 2015.
- Details
Programme
Agenda
{gallery}annual-meeting-2015{/gallery}
BioMed Alliance welcomes European Commission reply to "Stop Vivisection" European Citizens' Initiative
- Details
The Alliance for Biomedical Research in Europe (BioMed Alliance) welcomes the European Commission's decision not to repeal Directive 2010/63/EU on the protection of animals used for scientific purposes, in response to the ECI “Stop Vivisection”. Animal studies continue to provide invaluable insights into basic biological processes and are instrumental in unravelling disease mechanisms and pathways. To ensure continued advancement in the prevention of diseases and the development of safe and efficacious, treatments, a complete replacement of animal studies would at this time be premature.
Horizon 2020 budget cuts are threatening Research
- Details
Brussels, 5 June 2015. The Alliance for Biomedical Research in Europe (BioMed Alliance) welcomes the announcement that the European Research Council (ERC) and the Marie Skłodowska-Curie Actions budget lines have been safeguarded following the political negotiations on the European Fund for Strategic Investments (EFSI). Basic science and education and mobility for researchers are vital instruments for scientists to conduct frontier research in Europe.
In memory of Prof. Jose Mariano Gago
- Details
It is with great sadness we learned of the death of Prof. Jose Mariano Gago on April 17, 2015. He will be very much missed.
Biomed Alliance General Annual Meeting November 2014, Brussels
- Details
Programme
Agenda
List of attendees
Presentations
H2020 the current status
Ruxandra Draghia-Akli – Director of the Health Directorate, DG
Research & Innovation
The European Research Council and biomedical & health research
Eva Kondorosi – ERC Scientific Council Member
Science Europe and biomedical sciences driven policies
Nathalie Kayadjanian – Senior Scientific Officer, Science
Europe
European policy and biomedical research
Teresa Riera Madurell – Advisor, BioMed Alliance
Cancer Core Europe: A first step towards a virtual cancer institute in Europe?
- Details
During the last decades, we have witnessed remarkable advances in basic cancer research as well as related disciplines. These developments together with the advent of novel and powerful technologies have provided new opportunities for delineating innovative clinical research strategies.